Lawsuit for Investors in Stemline Therapeutics Inc (NASDAQ:STML) over Alleged Violations of Securities Laws Filed
An investor, who purchased shares of Stemline Therapeutics Inc (NASDAQ:STML), filed a lawsuit in New York over alleged Securities Laws violations by Stemline Therapeutics Inc in connection with certain allegedly false and misleading statements.
View full press release